Pfizer surged 15% last week on positive news, including a direct-to-consumer deal and a three-year tariff reprieve. Read why PFE stock is a Buy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback